Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Fardoun

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
World Journal of Urology|February 12, 2015
Analysis of the impact of adherent perirenal fat on peri-operative outcomes of robotic partial nephrectomyZine-Eddine Khene, Benoit Peyronnet, Romain Mathieu, et al.
World Journal of Urology|July 8, 2018
Cost analysis of prostate cancer detection including the prostate health index (phi)Romain Mathieu, Christel Castelli, Tarek Fardoun, et al.
The Journal of Urology|July 24, 2012
Detailed analysis of morbidity following nephrectomy for renal cell carcinoma in octogenariansJulien Berger, Tarek Fardoun, Elena Brassart, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 31, 2012
Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: a retrospective study on preoperative prognostic factorsElena Brassart, Souhil Lebdai, Julien Berger, et al.
BJU International|May 3, 2017
Does training of fellows affect peri-operative outcomes of robot-assisted partial nephrectomy?Zine-Eddine Khene, Benoit Peyronnet, Elise Bosquet, et al.
The Journal of Urology|May 7, 2013
Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomyGuillaume Ploussard, Frédéric Staerman, Jean Pierrevelcin, et al.
World Journal of Urology|April 30, 2013
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?Pierre Bigot, Tarek Fardoun, Jean Christophe Bernhard, et al.
World Journal of Urology|November 26, 2013
Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre studyGuillaume Ploussard, Frédéric Staerman, Jean Pierrevelcin, et al.
Clinical Genitourinary Cancer|November 12, 2013
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomesPierre Bigot, Jean-François Hétet, Jean-Christophe Bernhard, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
World Journal of Urology|February 12, 2015
Analysis of the impact of adherent perirenal fat on peri-operative outcomes of robotic partial nephrectomyZine-Eddine Khene, Benoit Peyronnet, Romain Mathieu, et al.
World Journal of Urology|July 8, 2018
Cost analysis of prostate cancer detection including the prostate health index (phi)Romain Mathieu, Christel Castelli, Tarek Fardoun, et al.
The Journal of Urology|July 24, 2012
Detailed analysis of morbidity following nephrectomy for renal cell carcinoma in octogenariansJulien Berger, Tarek Fardoun, Elena Brassart, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 31, 2012
Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: a retrospective study on preoperative prognostic factorsElena Brassart, Souhil Lebdai, Julien Berger, et al.
BJU International|May 3, 2017
Does training of fellows affect peri-operative outcomes of robot-assisted partial nephrectomy?Zine-Eddine Khene, Benoit Peyronnet, Elise Bosquet, et al.
The Journal of Urology|May 7, 2013
Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomyGuillaume Ploussard, Frédéric Staerman, Jean Pierrevelcin, et al.
World Journal of Urology|April 30, 2013
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?Pierre Bigot, Tarek Fardoun, Jean Christophe Bernhard, et al.
World Journal of Urology|November 26, 2013
Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre studyGuillaume Ploussard, Frédéric Staerman, Jean Pierrevelcin, et al.
Clinical Genitourinary Cancer|November 12, 2013
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomesPierre Bigot, Jean-François Hétet, Jean-Christophe Bernhard, et al.
Pageof 1